本邦でも透析患者のTAVIが始まることについて、期待感を持ったツイートと、医療費への懸念のツイートが散見されますね。JACC CIのUKからの報告でもHDのTAVIは非HDよりも死亡率が高く(2年生存率75% vs 50%)、Kuno先生のCJCのメタアナでもHDは合併症率が高いとなっております。患者選択が重要そうです。
In this proof-of-concept study, a novel device named Cusper, made of a nitinol clip with a pericardial sac, was tested for transcatheter aortic valve repair (TAVr) in ex-vivo and in-vivo porcine models of aortic regurgitation.
カテ後はクロピドで
Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial
Our publication in JASE showed that the time difference between mitral and tricuspid valve opening well predict elevated LV filling pressure.
Simple Two-Dimensional Echocardiographic Scoring System for the Estimation of Left Ventricular Filling Pressure
ABYSS trial showed interrupting B-blocker in MI with preserved LVEF > 40% is not different from continuing B-blockers with regards to composite of death, MI, stroke, or CV hospitalization. Interrupting B-blockers resulted in higher hospitalization rate
#ESCCongress
#cardiology